HIGHLIGHTS
- who: MDPI from the University Graduate School of Medicine, Tomioka, Urayasu, Chiba, Japan have published the research work: Type of the Paper (Article, in the Journal: Cells 2023, 12, 239. of 11/Nov/2022
- what: This study investigated changes in clinical scores serum biomarkers and the number of intraepidermal nerve fibers (IENFs) using skin biopsies and blood samples from 12 patients with moderate to severe AD before and after treatment with dupilumab. This study was conducted according to the Declaration of Helsinki and was approved by the Ethical Committee of Juntendo University Urayasu Hospital (approval . . .
If you want to have access to all the content you need to log in!
Thanks :)
If you don't have an account, you can create one here.